Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in Net LoansChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abvc Biopharma (ABVC) Short-Term Debt issuances (2018 - 2024)

Abvc Biopharma (ABVC) has disclosed Short-Term Debt issuances for 4 consecutive years, with $30000.0 as the latest value for Q1 2024.

  • For the quarter ending Q1 2024, Short-Term Debt issuances changed N/A year-over-year to $30000.0, compared with a TTM value of $30000.0 through Dec 2024, changed N/A, and an annual FY2024 reading of $30000.0, changed N/A over the prior year.
  • Short-Term Debt issuances was $30000.0 for Q1 2024 at Abvc Biopharma, up from -$412212.0 in the prior quarter.
  • Across five years, Short-Term Debt issuances topped out at $480362.0 in Q3 2020 and bottomed at -$412212.0 in Q4 2020.